Beyfortus for RSV protection is now available!
By Dr. Joseph Mechak A new preventative medication for RSV! Last year we gained a fantastic new tool that helps prevent hospitalizations and deaths related to the Respiratory Syncytial Virus (RSV). Nirsevimab (Beyfortus) is a monoclonal antibody targeted against RSV that received both FDA approval and a CDC recommendation in 2023. We are SO
Read more
Most Commented